What is Leerink Partnrs’ Forecast for BEAM Q2 Earnings?
Beam Therapeutics Inc. (NASDAQ:BEAM – Free Report) – Research analysts at Leerink Partnrs issued their Q2 2025 earnings estimates for shares of Beam Therapeutics in a report issued on Tuesday, February 25th. Leerink Partnrs analyst M. Foroohar anticipates that the company will post earnings per share of ($1.28) for the quarter. Leerink Partnrs currently has […]
Beam Therapeutics Inc. (NASDAQ:BEAM – Free Report) – Research analysts at Leerink Partnrs issued their Q2 2025 earnings estimates for shares of Beam Therapeutics in a report issued on Tuesday, February 25th. Leerink Partnrs analyst M. Foroohar anticipates that the company will post earnings per share of ($1.28) for the quarter. Leerink Partnrs currently has […]
